Close
  • Latest News
  • Cybersecurity
  • Big Data and Analytics
  • Cloud
  • Mobile
  • Networking
  • Storage
  • Applications
  • IT Management
  • Small Business
  • Development
  • Database
  • Servers
  • Android
  • Apple
  • Innovation
  • Blogs
  • PC Hardware
  • Reviews
  • Search Engines
  • Virtualization
Read Down
Sign in
Close
Welcome!Log into your account
Forgot your password?
Read Down
Password recovery
Recover your password
Close
Search
Menu
eWEEK.com
Search
eWEEK.com
  • Latest News
  • Cybersecurity
  • Big Data and Analytics
  • Cloud
  • Mobile
  • Networking
  • Storage
  • Applications
  • IT Management
  • Small Business
  • Development
  • Database
  • Servers
  • Android
  • Apple
  • Innovation
  • Blogs
  • PC Hardware
  • Reviews
  • Search Engines
  • Virtualization
More
    Home Latest News
    • Mobile

    IBC, Penn Medicine to Study Pill Caps for Drug Adherence

    By
    BRIAN T. HOROWITZ
    -
    July 14, 2013
    Share
    Facebook
    Twitter
    Linkedin

      Independence Blue Cross (IBC) and the University of Pennsylvania Health System (Penn Medicine) are launching a study to determine how electronic pill caps help patients adhere to their medication regimens.

      Researchers will examine if the beeping devices help improve medication adherence.

      Vitality’s GlowCap fits on ordinary pill bottles from a pharmacy and offers medication reminders, social feedback, financial incentives and automatic refills. A chip inside the cap detects when a pill bottle is opened and sends an alert wirelessly over AT&T’s Mobile Broadband Network. The data can then be transmitted to the database of IBC, an insurer for more than 7 million in the United States, including 2.2 million in southeastern Pennsylvania.

      The cap alerts a patient to take medication by shining a glowing light, playing a tune, triggering automated calls, or sending text messages or emails.

      “One of the greatest challenges to improving health care today centers on changing the behaviors that lead to poor health, whether that is eating right and exercising, getting appropriate tests and screenings, or taking the medications doctors prescribe,” Dr. Kevin Volpp, director of the Center for Health Incentives and Behavioral Economics at the University of Pennsylvania, said in a statement. Volpp leads many of the research projects as part of the collaboration between IBC and Penn.

      To identify patients for the pill cap study, researchers will examine data from medical claims and authorization records as well as health data from Penn Medicine, Somesh Nigam, senior vice president and chief informatics officer for IBC, told eWEEK.

      IBC and Penn Medicine chose to study patients who have suffered a heart attack, have a history of poor outcomes, and have been prescribed several drugs such as beta blockers and statins to help them avoid a secondary heart attack, he said.

      “It’s a very vulnerable population,” Nigam said. Medication adherence rates can drop from 50 to 60 percent to 20 to 30 percent when patients are feeling better, leaving them vulnerable to a second heart attack, he said.

      “At some point patients start feeling well, and their rates go down at almost a straight line,” Nigam said.

      “Evidence shows that patients who take medications such as cholesterol-lowering drugs as prescribed have a much lower likelihood of being readmitted to the hospital or having another heart attack,” Volpp said.

      “We know that there are tremendous health benefits to increasing medication adherence and improving health behaviors to reduce patients’ risk of disease,” Volpp added. “It’s just a matter of figuring out the best ways to achieve the desired behaviors.”

      A 2010 study by the Center for Connected Health found a 27 percent increase in medication schedule adherence by users of the Vitality GlowCaps.

      The GlowCap now has more efficient wireless connectivity since a few years ago, Nigam said. “The technology in this trial looks a lot more streamlined,” he said. Some issues have also been resolved as far as the fit between the pill bottles and the GlowCap, he said.

      Although other medication adherence projects have not worked, researchers are hopeful the GlowCap will have positive results, according to Nigam.

      IBC and Penn Medicine are currently enrolling patients for the study, and results could be available by the middle or second half of 2014, he said.

      Often the number of people identified as candidates for the study by health data is larger than the people who actually enroll, Nigam noted.

      “We’re trying to really enhance the enrollment rate, and that can really bring the timelines forward,” he said.

      In addition to the GlowCap study, IBC is looking into how text messaging and other mobile technologies can play a role in medication adherence for patients with chronic obstructive pulmonary disease (COPD), diabetes and hypertension.

      “We think that cell phone technology will play a huge role in improving medication adherence and patient outcomes for a whole host of chronic conditions,” Nigam said.

      Through text messaging, a patient can answer simple yes-or-no questions as well as simple questions such as “How are you feeling today?” or “Do you have pain?” he said.

      “You can really ask those questions specific to the disease and get a fairly good idea about where that patient’s state is,” Nigam said.

      The pill cap study is part of a collaboration that IBC and Penn Medicine announced on June 27. In addition to medication adherence, researchers will study how genomic testing can improve clinical outcomes and reduce cancer care costs.

      MOST POPULAR ARTICLES

      Android

      Samsung Galaxy XCover Pro: Durability for Tough...

      CHRIS PREIMESBERGER - December 5, 2020 0
      Have you ever dropped your phone, winced and felt the pain as it hit the sidewalk? Either the screen splintered like a windshield being...
      Read more
      Cloud

      Why Data Security Will Face Even Harsher...

      CHRIS PREIMESBERGER - December 1, 2020 0
      Who would know more about details of the hacking process than an actual former career hacker? And who wants to understand all they can...
      Read more
      Cybersecurity

      How Veritas Is Shining a Light Into...

      EWEEK EDITORS - September 25, 2020 0
      Protecting data has always been one of the most important tasks in all of IT, yet as more companies become data companies at the...
      Read more
      Big Data and Analytics

      How NVIDIA A100 Station Brings Data Center...

      ZEUS KERRAVALA - November 18, 2020 0
      There’s little debate that graphics processor unit manufacturer NVIDIA is the de facto standard when it comes to providing silicon to power machine learning...
      Read more
      Apple

      Why iPhone 12 Pro Makes Sense for...

      WAYNE RASH - November 26, 2020 0
      If you’ve been watching the Apple commercials for the past three weeks, you already know what the company thinks will happen if you buy...
      Read more
      eWeek


      Contact Us | About | Sitemap

      Facebook
      Linkedin
      RSS
      Twitter
      Youtube

      Property of TechnologyAdvice.
      Terms of Service | Privacy Notice | Advertise | California - Do Not Sell My Info

      © 2020 TechnologyAdvice. All Rights Reserved

      Advertiser Disclosure: Some of the products that appear on this site are from companies from which TechnologyAdvice receives compensation. This compensation may impact how and where products appear on this site including, for example, the order in which they appear. TechnologyAdvice does not include all companies or all types of products available in the marketplace.

      ×